Total Payments
$583.29
2023 Payments
$19.44
Companies
11
Transactions
39
Medicare Patients
436
Medicare Billing
$48,292
Payment Breakdown by Category
Food & Beverage$583.29 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $583.29 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $136.36 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $127.51 | 9 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $85.29 | 6 | $0 (2019) |
| PFIZER INC. | $72.65 | 6 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $51.22 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $26.35 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $23.41 | 2 | $0 (2018) |
| Novo Nordisk Inc | $19.44 | 1 | $0 (2023) |
| Abbott Laboratories | $18.73 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.44 | 1 | Novo Nordisk Inc ($19.44) |
| 2019 | $68.09 | 4 | Novartis Pharmaceuticals Corporation ($28.56) |
| 2018 | $117.33 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($56.57) |
| 2017 | $378.43 | 26 | Janssen Pharmaceuticals, Inc ($127.51) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 10/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/11/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/07/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.75 | General |
| Category: Cardiovascular | ||||||
| 03/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2017 | Abbott Laboratories | EnSite Velocity System Mapping Disposables (Device) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: DIABETES | ||||||
| 09/29/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/15/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, STIOLTO | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 121 | 132 | $27,720 | $11,546 |
| 2021 | 6 | 174 | 186 | $46,245 | $20,009 |
| 2020 | 6 | 141 | 195 | $43,375 | $16,738 |
Total Patients
436
Total Services
513
Medicare Billing
$48,292
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 61 | $12,505 | $5,484 | 43.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 21 | $6,615 | $2,807 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 30 | $4,200 | $1,710 | 40.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 20 | $4,400 | $1,545 | 35.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 35 | 35 | $11,025 | $5,704 | 51.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 51 | 52 | $11,440 | $5,245 | 45.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 19 | 19 | $8,455 | $3,561 | 42.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 38 | 39 | $7,020 | $2,565 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 21 | $4,305 | $1,913 | 44.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 20 | $4,000 | $1,022 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 51 | 92 | $18,400 | $7,442 | 40.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 12 | 14 | $6,230 | $2,728 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 28 | 28 | $7,700 | $2,227 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 25 | $5,125 | $2,002 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 25 | $3,500 | $1,382 | 39.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,420 | $957.22 | 39.6% |
About Dr. Anthony Buonanno, M.D
Dr. Anthony Buonanno, M.D is a Internal Medicine healthcare provider based in Lewes, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609873413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Buonanno, M.D has received a total of $583.29 in payments from pharmaceutical and medical device companies, with $19.44 received in 2023. These payments were reported across 39 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($583.29).
As a Medicare-enrolled provider, Buonanno has provided services to 436 Medicare beneficiaries, totaling 513 services with total Medicare billing of $48,292. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Internal Medicine
- Location Lewes, DE
- Active Since 07/07/2005
- Last Updated 07/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609873413
Products in Payments
- PRADAXA (Drug) $136.36
- XARELTO (Drug) $127.51
- ELIQUIS (Drug) $96.06
- ENTRESTO (Drug) $85.29
- LANTUS (Drug) $33.54
- ZERBAXA (Drug) $26.35
- EnSite Velocity System Mapping Disposables (Device) $18.73
- TOUJEO (Drug) $17.68
- BRILINTA (Drug) $11.28
- Reveal LINQ (Device) $11.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewes
Dr. Bhaskar Palekar, M.d, M.D
Internal Medicine — Payments: $26,371
Internal Medicine $26,371
Dr. Lourdes Aponte, Md, MD
Internal Medicine — Payments: $23,752
Internal Medicine $23,752
Charles Stanislav, Md, MD
Internal Medicine — Payments: $7,878
Internal Medicine $7,878
Dr. Monique Yost, M.d, M.D
Internal Medicine — Payments: $6,607
Internal Medicine $6,607
Jennifer Hurd, M.d, M.D
Internal Medicine — Payments: $6,305
Internal Medicine $6,305
Zeina Jeha, Md, MD
Internal Medicine — Payments: $4,928
Internal Medicine $4,928